Access Statistics for Darius Lakdawalla

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Aging and the Growth of Long-Term Care 0 0 0 30 1 1 6 150
Aging and the Growth of Long-Term Care 0 0 0 243 7 8 21 1,314
An Economic Evaluation of the War on Cancer 0 0 0 97 2 9 14 374
Are the Young Becoming More Disabled? 0 0 0 93 0 0 9 355
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer 0 0 1 153 2 6 18 562
Does Medicare Benefit the Poor? New Answers to an Old Question 0 0 0 67 1 1 8 387
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 23 4 4 13 49
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 85 2 3 10 45
Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey 0 0 0 55 0 2 8 265
Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn? 0 0 0 6 1 8 21 63
Effects of expanding health screening on treatment – What should we expect? What can we learn? 0 0 0 6 4 7 13 67
Evaluation of Medical Technologies with Uncertain Benefits 0 1 1 49 1 4 7 52
Food Prices and the Dynamics of Body Weight 0 0 0 71 3 7 12 244
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 1 4 10 645
Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses 0 0 0 13 0 4 13 66
Health Insurance as a Two-Part Pricing Contract 0 0 0 97 1 5 10 438
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 52 1 5 9 200
Insurance and Innovation in Health Care Markets 0 0 1 139 2 8 23 491
Insurance, Self-Protection, and the Economics of Terrorism 0 0 0 289 1 1 14 900
Insurer Bargaining and Negotiated Drug Prices in Medicare Part D 0 0 0 32 3 7 20 168
Insurers' Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 14 0 4 11 108
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 3 4 6 17 89
Intellectual Property and Marketing 0 0 0 0 0 0 9 15
Intellectual Property and Marketing 0 0 0 91 3 9 16 408
International Differences in Longevity and Health and Their Economic Consequences 0 0 0 35 2 4 12 134
International Differences in Longevity and Health and their Economic Consequences 0 0 0 55 4 7 17 187
International Differences in Longevity and Health and their Economic Consequences 0 0 0 51 1 2 6 270
Mortality Risk, Insurance, and the Value of Life 0 0 0 37 5 15 36 84
Nonprofit Production 0 0 0 0 3 4 8 204
Nonprofit Production and Competition 0 0 1 301 1 2 12 1,267
Optimal Liability for Terrorism 0 0 0 40 1 2 9 224
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D 0 0 0 24 1 2 10 106
Risk Preferences Over Health: Empirical Estimates and Implications for Healthcare Decision-Making 0 0 0 15 4 5 15 24
The Declining Quality of Teachers 0 0 0 222 4 12 22 1,721
The Effect of US COVID-19 Excess Mortality on Social Security Outlays 0 0 0 6 2 7 22 27
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 0 89 3 4 15 386
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 0 0 1 4 14 19
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 0 492 1 3 19 1,622
The Insurance Value of Medical Innovation 0 0 0 34 4 9 15 121
The Rise in Old Age Longevity and the Market for Long-Term Care 0 0 0 3 1 2 7 778
The Rise in Old Age Longevity and the Market for Long-Term Care 0 0 0 234 1 5 12 1,787
The Value of Medican and Pharmaceutical Interventions for Reducing Obesity 0 0 0 29 3 6 14 179
The Welfare Effects of Medical Malpractice Liability 0 0 0 101 3 4 9 483
The Welfare Effects of Public Drug Insurance 0 1 1 78 1 7 15 302
Time-Inconsistency and Welfare 0 0 0 79 0 0 13 390
Understanding Health Disparities Across Education Groups 1 2 2 400 1 3 15 1,716
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 50 3 3 14 192
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 36 0 3 5 116
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 43 1 2 10 235
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market 0 0 0 15 0 5 14 122
Vaccine Allocation Priorities Using Disease Surveillance and Economic Data 0 0 1 3 2 5 16 30
Total Working Papers 1 4 8 4,264 97 240 688 20,181

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies 0 0 0 57 3 7 16 231
A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis 1 1 1 3 6 10 17 36
A Theory of Health Disparities and Medical Technology 0 1 2 147 4 8 24 636
A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE) 0 0 0 2 3 8 13 33
A principled approach to non-discrimination in cost-effectiveness 0 0 0 0 4 7 15 16
An economic evaluation of the war on cancer 2 2 2 110 5 6 16 596
Are Biopharmaceutical Budget Caps Good Public Policy? 1 1 2 14 1 5 12 84
Are investments in disease prevention complements? The case of statins and health behaviors 0 0 0 11 0 3 13 92
Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital? 0 0 0 35 1 4 12 191
Can the ACA Improve Population Health? 0 0 0 14 5 7 13 81
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk Transfer 0 0 1 20 4 9 18 123
Differences in health between Americans and Western Europeans: Effects on longevity and public finance 0 0 0 27 5 14 19 127
Disability Forecasts and Future Medicare Costs 0 0 1 35 2 2 9 281
Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets 0 0 0 40 1 5 13 182
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 2 3 6 10 27
Does Medicare benefit the poor? 0 0 0 139 1 2 6 347
Economics of the Pharmaceutical Industry 0 0 8 317 0 3 26 726
Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA 0 0 0 3 6 6 10 30
Geographic Variation in Health Care: The Role of Private Markets 0 0 0 75 4 7 12 431
HIV Breakthroughs and Risky Sexual Behavior 0 0 0 166 2 3 14 931
HOW DOES HEALTH INSURANCE AFFECT WORKERS’ COMPENSATION FILING? 0 0 0 15 3 6 14 298
HOW DOES TERRORISM RISK VARY ACROSS SPACE AND TIME? AN ANALYSIS BASED ON THE ISRAELI EXPERIENCE 1 1 4 103 6 8 25 336
Healing the poor: The influence of patient socioeconomic status on physician supply responses 0 0 0 3 2 7 17 85
Health insurance as a two-part pricing contract 0 0 0 49 3 6 17 377
Health risk and the value of life 0 1 4 4 6 9 24 24
Health technology assessment with risk aversion in health 0 0 0 9 5 7 19 65
Innovation and the welfare effects of public drug insurance 0 0 1 46 2 2 11 169
Insurance, self-protection, and the economics of terrorism 0 0 0 81 2 3 10 325
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 16 3 5 11 146
Is nursing home demand affected by the decline in age difference between spouses? 0 0 0 26 2 3 6 330
Labor Supply and Weight 1 1 2 51 2 7 22 158
Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants 0 0 2 51 0 1 10 194
Pharmaceutical advertising and Medicare Part D 0 0 1 13 4 9 18 165
Predicting quantity and quality of life with the Future Elderly Model 0 0 0 2 2 7 12 25
Prescription drug advertising and drug utilization: The role of Medicare Part D 0 0 2 4 3 6 32 46
Public Financing and the Market for Long-Term Care 0 0 0 24 0 1 8 107
Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets 0 0 1 15 3 5 13 108
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection 0 0 0 41 0 0 12 165
Risk preferences over health: Empirical estimates and implications for medical decision-making 0 0 1 2 5 8 21 26
Social insurance and the design of innovation incentives 0 1 1 21 3 7 13 100
The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 0 0 0 72 4 5 13 309
The Economics of Teacher Quality 0 0 0 6 1 4 16 234
The Fiscal Consequences of Trends in Population Health 0 0 0 15 2 4 10 75
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation 0 0 0 3 7 11 16 37
The Labor Market Value of Health Improvements 0 0 0 45 2 5 14 166
The Rise in Old-Age Longevity and the Market for Long-Term Care 0 0 0 106 1 7 16 459
The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson’s Disease Population 0 0 0 2 0 2 12 33
The Value of Diagnostic Testing in Personalized Medicine 0 1 1 61 1 4 7 230
The economics of alternative payment models for pharmaceuticals 0 0 0 9 3 4 13 51
The growth of obesity and technological change 0 0 0 32 3 13 31 167
The insurance value of medical innovation 0 0 2 43 4 10 25 194
The nonprofit sector and industry performance 2 2 4 259 7 19 31 737
The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions 0 0 0 4 5 6 15 62
The value of medical and pharmaceutical interventions for reducing obesity 0 0 0 15 3 4 10 107
The welfare effects of medical malpractice liability 0 0 0 15 4 6 18 168
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market* 0 0 1 1 2 7 17 26
Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA 0 0 0 26 4 6 10 110
Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices 1 1 1 2 2 7 13 18
Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall 0 0 0 1 1 4 10 27
Welfare-Enhancing Technological Change and the Growth of Obesity 0 0 0 152 1 5 15 443
Total Journal Articles 9 13 45 2,662 173 362 915 12,103

Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Disability Forecasts and Future Medicare Costs 0 0 0 23 2 5 11 118
Economics of Obesity 0 0 0 37 2 3 11 109
Economics of Obesity 1 3 3 28 2 7 11 102
Food Prices and the Dynamics of Body Weight 0 0 0 14 3 3 14 86
Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products 0 0 3 104 1 1 14 270
Medical Care Output and Productivity in the Nonprofit Sector 0 0 0 12 0 2 11 73
Patents, innovation, and the welfare effects of Medicare Part D 0 0 0 0 0 1 8 9
Public Financing and the Market for Long-Term Care 0 0 0 8 3 3 9 61
Total Chapters 1 3 6 226 13 25 89 828

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-05-06